FDA
approval
· 2022-04-29
FDA Approved: KARIVA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved a supplemental application for KARIVA (desogestrel/ethinyl estradiol), maintaining regulatory approval for this combined oral contraceptive.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for KARIVA (DESOGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL)